unknown
Stage
About
Cadex Genomics develops blood-based assays for real-time monitoring of therapy effectiveness in stage IV solid tumor cancer patients, enabling faster detection of disease progression than standard imaging methods.
Explore Cadex Genomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.